Contract V797D6039E
Hikma Specialty USA Inc · Department Of Veterans Affairs · May 24, 2016
Hikma Specialty USA Inc was awarded a federal contract by Department Of Veterans Affairs on May 24, 2016 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 27, 2017. If all options are exercised, the contract could reach $25,000.
Contract details
- PIID
- V797D6039E
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- May 24, 2016
- Latest action
- January 27, 2017
Description
65IB: DRUGS, PHARMACEUTICALS AND HEMATOLOGY RELATED PRODUCTS
Modification timeline
-
January 27, 2017Mod P00004$0
-
December 5, 2016Mod P00003$0
-
November 22, 2016Mod P00002$0
-
June 16, 2016Mod P00001NON-TAA LANGUAGE$0
-
May 24, 2016Base award65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCT FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D6039E?
Contract V797D6039E is a federal contract awarded to Hikma Specialty USA Inc by Department Of Veterans Affairs on May 24, 2016 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract V797D6039E?
Hikma Specialty USA Inc won contract V797D6039E from Department Of Veterans Affairs.
How much is contract V797D6039E worth?
Contract V797D6039E has obligated $0 to date but carries a potential ceiling of $25,000 if fully funded and all options are exercised.